Added to YB: 2025-07-16
Pitch date: 2025-07-14
HIMS [bullish]
Hims & Hers Health, Inc.
-31.6%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$8.9B
Pitch Price
$53.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
52.94
P/E
73.02
EV/Sales
4.26
Sector
Health Care Providers and Services
Category
growth
Hims & Hers: Home lab tests for blood diagnosis are coming
HIMS: Entering blood diagnostics market via TrybeLabs acquisition. Home test kits will cover heart, hormones, liver, thyroid & cancer biomarkers. FDA-approved device provides smartphone health insights. Expands into $109.65B cancer diagnostics market (projected $199.54B by 2034). Bigger growth opportunity than GLP-1 drugs.
Read full article (3 min)